Archives for July, 2018 - Page 2
Alvogen, Prestige BioPharma in Hervelous selling deal for Central and Eastern Europe
Custom Synthesis, Alvogen and Prestige BioPharma have entered into a deal for the exclusive partnership and supply for the commercialization of Prestige BioPharma´s Trastuzumab biosimilar...
Myocant Sciences complets screening patients for heavy menstrual bleeding study
Custom Synthesis, Myovant Sciences has completed screening patients for its LIBERTY 1 study, the first of two Phase 3 replicate studies evaluating relugolix in...
NICE backs EUSA Pharma’s Qarziba for children
Custom Synthesis,The National Institute for Health and Care Excellence (NICE) has recommended the use of the EUSA Pharma’s targeted cancer immunotherapy, QARZIBA (dinutuximab beta)...
Wasdell Group launch serialisation service
Custom Synthesis, The Wasdell Group (Wasdell) has launched its serialisation service ahead of the EU FMD and US DSCSA implementation deadlines. Wasdell, an outsourcing partner...